Denali Capital Acquisition Corp. completes $82.5M IPO and $5.1M private placement

Semnur Pharmaceuticals, Inc.

IPO of 8,250,000 units at $10.00/unit raised $82.5M gross; private placement of 510,000 units to sponsor raised $5.1M.
Total $84.15M deposited into trust account for benefit of public shareholders; redemption value set at $10.20/share.
Company has 12 months (extendable to 18) to complete a business combination or will liquidate.
Each unit consists of one Class A share and one warrant exercisable at $11.50 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.